is compounded semaglutide dangerous Hims & Hers' Super Bowl ad turns up the heat on GLP-1 battle Dangers of 'Compounded Semaglutide' Explained

Clinical trials reveal that semaglutide (Wegovy) achieves around 12% weight loss, while tirzepatide (Mounjaro) leads to approximately 18%

Be conscious of your portion sizes and increase your non-starchy vegetables

To ensure the successful implementation of GLP-1 therapy, patient education plays a critical role

Footnotes Conflicts of interest No potential conflict of interest relevant to this article was reported

In addition to your doctor, a registered dietitian can help you create a meal plan tailored to your needs

Nausea, vomiting, diarrhoea, stomach pain, constipation and headache are among the most common side effects